Revolution Medicines Inc (NASDAQ:RVMD) shares are trading lower by 11.25% to $21.82 Wednesday morning after the company announced the pricing of its underwritten public offering of 11,500,000 shares of common stock at a public offering price of $20.00 per share.
Revolution Medicines says the offering is expected to close on July 22, subject to customary closing conditions.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
See Also: If You Invested $100 In Bitcoin, Ethereum And Dogecoin 5 Years Ago, Here's How Much You'd Have Now
Revolution Medicines is a clinical-stage precision oncology company.
According to data from Benzinga Pro, Revolution Medicines has a 52-week high of $34.16 and a 52-week low of $14.08.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.